Amgen (AMGN) Other Working Capital Changes (2009 - 2026)

Amgen has reported Other Working Capital Changes for 18 years, with the latest figure at -$8.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes fell 103.98% year-over-year to -$8.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 38.48% YoY), and the FY2025 full-year result was $1.3 billion, up 94.33% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$8.0 million, down from $577.0 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $577.0 million in Q4 2025, with the low at -$241.0 million in Q2 2022.
• Average Other Working Capital Changes over 5 years is $130.4 million, with a median of $139.0 million recorded in 2023.
• Year-over-year, Other Working Capital Changes slumped 315.18% in 2022 and surged 4021.43% in 2025.
• Tracing AMGN's Other Working Capital Changes over 5 years: stood at -$92.0 million in 2022, then surged by 352.17% to $232.0 million in 2023, then plunged by 93.97% to $14.0 million in 2024, then surged by 4021.43% to $577.0 million in 2025, then sank by 101.39% to -$8.0 million in 2026.
• The last three Other Working Capital Changes figures came in at -$8.0 million (Q1 2026), $577.0 million (Q4 2025), and $283.0 million (Q3 2025), per Business Quant data.

Peer Comparison